Sanguinarine

Pharmacology & Research

Sanguinarine is a genuinely toxic red-orange benzophenanthridine alkaloid found in bloodroot (Sanguinaria canadensis), greater celandine (Chelidonium majus), plume poppy and other Papaveraceae. It is richest in root, latex and cell culture and only a trace constituent of the aerial parts of Chelidonium and California poppy — an important boundary, because this page is about the isolated molecule and its cytotoxicity should not be read onto those trace-level whole-herb products. Its pharmacology has real preclinical breadth (antimicrobial, anticancer, anti-inflammatory), but the two facts that define it are human ones: it was the active in Viadent oral-care products, which were withdrawn after being linked to oral leukoplakia, and it is the poison behind argemone-oil epidemic dropsy ^{14,19Reference 14Damm DD et al. · 1999Leukoplakia of the maxillary vestibule — an association with Viadent? Oral Surgery, Oral Medicine, Oral Pathology. https://pubmed.ncbi.nlm.nih.gov/9927082/View study →Reference 19Das M · 1997ObservationalClinicoepidemiological, toxicological and safety evaluation studies on argemone oilView study →}. It has no approved therapeutic use.

1. Antimicrobial / anti-plaque

Sanguinaria extract standardised to sanguinarine (plus zinc) was the active in Viadent toothpaste and mouthrinse; controlled trials showed modest, mostly short-term plaque and gingivitis reductions ^{10,11Reference 101991Clinical and microbiological effects of a sanguinaria-containing mouthrinse and dentifriceView study →Reference 111990Effect of 6 months’ use of a dentifrice and oral rinse containing sanguinaria extract and zincView study →}, including as an adjunct after scaling and root planing ^{12Reference 121999Effectiveness of a sanguinarine regimen after scaling and root planingView study →}.

Gap: the benefit is small and inconsistent versus chlorhexidine ^{13Reference 132005RCTRandomised controlled clinical trials on agents used for chemical plaque controlView study →}, and — decisively — the same mucosal exposure route was linked to oral leukoplakia and the product was withdrawn (see Toxicity). The safety signal outweighs the efficacy ^{14Reference 14Damm DD et al. · 1999Leukoplakia of the maxillary vestibule — an association with Viadent? Oral Surgery, Oral Medicine, Oral Pathology. https://pubmed.ncbi.nlm.nih.gov/9927082/View study →}.

2. Anticancer

Sanguinarine induces apoptosis across many tumour lines — for example in non-small-cell lung cancer via a ROS/mitochondrial pathway ^{7Reference 72021Sanguinarine-mediated apoptosis in non-small-cell lung cancer via generation of reactive oxygen speciesView study →} — a large literature summarised in mechanism reviews ^{3,2Reference 32023Molecular mechanisms of sanguinarine in cancer prevention and treatmentView study →Reference 2Mackraj I et al. · 2016Sanguinarine and its role in chronic diseasesView study →}.

Gap: entirely preclinical, with no human trials, and the same cytotoxicity is a general-toxicity liability; the compound is also genotoxic, a poor drug-development profile ^{20Reference 202017Carcinogenic potential of sanguinarine, a phytochemical used in “therapeutic” black salve and mouthwashView study →}.

3. Anti-inflammatory

Sanguinarine is a potent NF-κB inhibitor (IκBα-dependent) ^{4Reference 4Chaturvedi MM et al. · 1997Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-κB activation and IκBα phosphorylationView study →} and a non-redox 5-/12-lipoxygenase inhibitor in cell and enzyme assays ^{6,2Reference 6Vavrečková C et al. · 1996Benzophenanthridine alkaloids of Chelidonium majus; I: inhibition of 5- and 12-lipoxygenaseView study →Reference 2Mackraj I et al. · 2016Sanguinarine and its role in chronic diseasesView study →}.

Gap: purely mechanistic, with no in-vivo therapeutic or clinical anti-inflammatory outcome data ^{4Reference 4Chaturvedi MM et al. · 1997Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-κB activation and IκBα phosphorylationView study →}.

4. Antifungal

Sanguinarine (from Macleaya cordata) shows potent activity against Candida species in culture ^{9Reference 92022Sanguinarine, isolated from Macleaya cordata, exhibits potent antifungal efficacy against CandidaView study →}.

Gap: in-vitro only, and systemic use is precluded by its toxicity and poor oral bioavailability ^{9Reference 92022Sanguinarine, isolated from Macleaya cordata, exhibits potent antifungal efficacy against CandidaView study →}.

Mechanisms

Target / pathway	Effect	Relevant to
Cardiac Na⁺/K⁺-ATPase	inhibition → positive inotropy (cardiotonic/cardiotoxic)	cardiac toxicity; epidemic-dropsy effects
NF-κB (IκBα-dependent)	blocks activation → ↓ inflammatory transcription	anti-inflammatory; anticancer
5-/12-lipoxygenase	non-redox inhibition → ↓ leukotrienes	anti-inflammatory
STAT3 / apoptosis (Bax/Bcl-2, caspases, ROS)	pro-apoptotic, mitochondrial	anticancer (preclinical)
DNA intercalation (iminium form binds nucleic acids)	DNA adducts / genotoxicity	genotoxicity; carcinogenicity concern

Pharmacokinetics

Poor oral bioavailability and rapid clearance are load-bearing. In rats, orally dosed sanguinarine is poorly absorbed, widely distributed and rapidly eliminated, largely as the reduced metabolite dihydrosanguinarine ^{8Reference 82007AnimalDisposition of sanguinarine in the ratView study →}. Sanguinarine also exists in a pH-dependent equilibrium between the charged iminium (quaternary) form — dominant and DNA-reactive at acidic/neutral pH — and the neutral alkanolamine (pseudobase) form that predominates in alkaline conditions and crosses membranes more readily ^{1Reference 1Croaker A et al. · 2016Sanguinaria canadensis: traditional medicine, phytochemical composition, biological activities and current usesView study →}. This equilibrium governs both cellular uptake and reactivity, so “sanguinarine exposure” is really exposure to a mixture whose ratio shifts with local pH.

Clinical trials

The only substantial human exposure is oral care: sanguinaria/sanguinarine-plus-zinc dentifrice and mouthrinse (Viadent). Controlled trials reported modest short-term plaque and gingivitis reductions ^{10,11Reference 101991Clinical and microbiological effects of a sanguinaria-containing mouthrinse and dentifriceView study →Reference 111990Effect of 6 months’ use of a dentifrice and oral rinse containing sanguinaria extract and zincView study →}, including after scaling and root planing ^{12Reference 121999Effectiveness of a sanguinarine regimen after scaling and root planingView study →}, but reviews of chemical plaque-control agents rank the effect as small and inconsistent ^{13Reference 132005RCTRandomised controlled clinical trials on agents used for chemical plaque controlView study →}. There are no oncology, anti-inflammatory or antimicrobial clinical trials of systemic sanguinarine — and the Viadent history is a cautionary tale, not a success.

Last checked: July 2026.

Toxicity & Safety

Sanguinarine is a genuinely toxic quaternary benzophenanthridine alkaloid — not a benign botanical. Its toxicity spans cellular cytotoxicity, genotoxicity via DNA intercalation, and cardiac Na⁺/K⁺-ATPase inhibition ^{5,20,1Reference 5Seifen E et al. · 1979Sanguinarine: a positive inotropic alkaloid which inhibits cardiac Na⁺,K⁺-ATPaseView study →Reference 202017Carcinogenic potential of sanguinarine, a phytochemical used in “therapeutic” black salve and mouthwashView study →Reference 1Croaker A et al. · 2016Sanguinaria canadensis: traditional medicine, phytochemical composition, biological activities and current usesView study →}, and a 90-day pig feeding study defined only relatively low no-adverse-effect exposures for the sanguinarine/chelerythrine pair, underscoring a narrow margin ^{18Reference 18Kosina P et al. · 2004Sanguinarine and chelerythrine: assessment of safety in pigs in a ninety-day feeding experimentView study →}. Three human-relevant signals anchor the flag:

• Oral leukoplakia (Viadent). Use of sanguinaria-containing dentifrice/rinse was epidemiologically linked to leukoplakia of the maxillary vestibule, a distinctive and often persistent white lesion ^{14Reference 14Damm DD et al. · 1999Leukoplakia of the maxillary vestibule — an association with Viadent? Oral Surgery, Oral Medicine, Oral Pathology. https://pubmed.ncbi.nlm.nih.gov/9927082/View study →}, characterised and compared with other leukoplakias ^{15Reference 15Eversole LR et al. · 2000Sanguinaria-associated oral leukoplakia: comparison with other benign and dysplastic leukoplakic lesionsView study →} and confirmed in matched case-control and epidemiological studies ^{16,17Reference 16Mascarenhas AK et al. · 2002ObservationalThe association between Viadent use and oral leukoplakia — a matched case-control studyView study →Reference 172001ObservationalThe association between Viadent use and oral leukoplakiaView study →}. Because the concern is a potentially (pre)malignant oral lesion from repeated mucosal exposure, this is the defining safety fact of the compound, and the product was withdrawn.
• Epidemic dropsy. Sanguinarine is the principal toxin in argemone (Argemone mexicana) oil, a notorious adulterant of edible mustard oil. Ingestion causes epidemic dropsy — bilateral pitting oedema, glaucoma, and cardiovascular/respiratory failure with deaths in outbreak settings — a serious systemic poisoning attributed to sanguinarine’s vascular and Na⁺/K⁺-ATPase effects ^{19Reference 19Das M · 1997ObservationalClinicoepidemiological, toxicological and safety evaluation studies on argemone oilView study →}.
• Genotoxicity / black salve. Sanguinarine is the active principle of corrosive “black salve” escharotics, and its DNA-intercalating iminium form and genotoxic signals have prompted formal assessment of its carcinogenic potential ^{20Reference 202017Carcinogenic potential of sanguinarine, a phytochemical used in “therapeutic” black salve and mouthwashView study →}.

Pregnancy & lactation

Avoid — contraindicated. A cytotoxic, genotoxic, DNA-intercalating alkaloid with documented systemic poisoning (epidemic dropsy) and no safety data in pregnancy or lactation is contraindicated in both.

Dosage

There is no established therapeutic dose, and none should be inferred. Historical human exposure was topical/oral-care (Viadent, ~0.03% sanguinaria extract), which was withdrawn over leukoplakia ^{14Reference 14Damm DD et al. · 1999Leukoplakia of the maxillary vestibule — an association with Viadent? Oral Surgery, Oral Medicine, Oral Pathology. https://pubmed.ncbi.nlm.nih.gov/9927082/View study →}; the other main human data point is harmful — argemone-oil adulteration causing epidemic dropsy ^{19Reference 19Das M · 1997ObservationalClinicoepidemiological, toxicological and safety evaluation studies on argemone oilView study →}. This section is framed by toxic exposures, not a dosing schedule.

References